Nasal potential difference test to diagnose cystic fibrosis;Prueba de la diferencia de potencial nasal para el diagnóstico de la fibrosis quística

Archivos de Bronconeumologia

Volumn 42, Issue 1, 2006, Pages 33-38

  Domingo Ribas, C ^a,b   Bosque Garcia M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Servicio de Oncología Médica   (Spain)

Author keywords

Cystic fibrosis; Diagnosis; Nasal potential difference

Indexed keywords

AMILORIDE; CHLORIDE; CHLORIDE CHANNEL; FENOTEROL; ISOPRENALINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CYSTIC FIBROSIS; DEVICE; DIAGNOSTIC TEST; DRUG RESPONSE; ELECTRODE; FALSE POSITIVE RESULT; GENE MUTATION; HUMAN; NASAL POTENTIAL DIFFERENCE TEST; NOSE MUCOSA; POTENTIOMETRY; PROTEIN FUNCTION; SWEAT TEST; TURBINATE;

EID: 32844459924     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083278     Document Type: Article

References (18)

1. Domingo Ribas C, Roig Cutillas J. Discinesia ciliar primaria. Med Clin (Barc). 1991;97:144-6.
2. Rosenstein BJ. What is cystic fibrosis diagnosis? Clin Chest Med. 1998;19:423-41.
3. Garner S, Cobos N, Asensio O, Bosque M, Seculi JL. Newborn screening in Catalonia. Fed Pulmonol. 2003;35 Suppl 10:325.
4. Cystic Fibrosis Genetic Analysis Consortium: population variation of common cystic fibrosis mutations. Hum Mutat. 1994;4:167-77.
5. Domingo C, Mirapeix RM, Encabo B, Roig J, López D, Ruiz J. Clínica y ultraestructura de la discinesia biliar primaria y el sindrome de Young. Rev Clin Esp. 1997;197:100-3.
6. Rosenstein BJ, Langbaum M. Diagnosis. En: Taussig LM, editor. Cystic fibrosis. Stuttgart, New York: Thieme-Straton Inc.; 1984. p. 85-114.
7. Wheeler WB, Colton HR. Cystic fibrosis: current approach to diagnosis and management. Pediatr Rev. 1988;9:241-8.
8. Wood RE, Boat TF, Doershuk CF. Cystic fibrosis: state of the art. Am Rev Respir Dis. 1976;113:833-78.
9. LeGrys VA. Sweat testing for the diagnosis of cystic fibrosis: practical considerations. J Pediatr. 1996;129:892-7.
10. Rosenstein BJ, Cutting G, for the cystic fibrosis foundation consensus panel. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr. 1998;132:589-95.
11. Bosque M, Larramona H, Asensio O, Montón C, Luján M, Domingo C. Papel del potencial diferencial nasal en el diagnóstico de fibrosis quística con test del sudor negativo. Arch Bronconeumol. 2003;39 Supl 2:137.
12. Knowles M, Gatzy J, Boucher R. Relative ion permeability of normal and cystic fibrosis nasal epithelium. Science. 1983;221:1067-9.
13. Gowen CW, Lawson EE, Gingras-Leatherman J, Gatsy JT, Boucher RC, Knowles MR. Increased nasal potential difference and amiloride sensitivity in neonates with cystic fibrosis. J Pediatr. 1986;108:517-21.
14. Duperrex O, Berclaz PY, Bertrand D, Lacroix JS, Pochon N, Belli D, et al. A new device for in vivo measurement of nasal transepithelial potential difference in cystic fibrosis patients and normal subjects. Eur Respir J. 1997;10:1631-6.
15. Middleton PG, Geddes DM, Alton EW. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J. 1994;7:2050-6.
16. Knowles M, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther. 1995;6:445-55.
17. Hofmann T, Böhmer O, Hüls G, Terbrack HG, Bittner P, Klingmüller V, et al. Conventional and modified nasal potential-difference measurement in cystic fibrosis. Am J Respir Crit Care Med. 1997;155:1908-13.
18. Ahrens RC, Standaert TA, Launspach J, Han SH, Teresi ME, Aitken ML, et al. Use of nasal potential difference and sweet chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis. Fed Pulmonol. 2002;33:142-50.